Gene Bridges GmbH Granted Korean Patent for Recombineering Technology
HEIDELBERG, Germany--(BUSINESS WIRE)--Gene Bridges GmbH, the recombineering company, announced that it has been granted Korean Patent No. 10-0751587, entitled "Methods and compositions for directed cloning and sub-cloning using homologous recombination" by the Korean Patent Office.